Treatments
Complementary and Alternative Treatments
- Physical treatments
- Repurposed Drugs – General
- No medication – Plan B
- Repurposed drugs and chemotherapy
- Repurposed drugs and radiation therapy
- FLCCC’s ranking of repurposed drugs
- Brain metastases and the blood-brain barrier
- Bombs, fire extinguishers, and timing
Doxycycline and cancer
Doxycycline is a broad-spectrum antibiotic primarily used to fight bacterial infections. However, in recent years, researchers have discovered that this substance may also have an interesting and promising effect on cancer cells. Therefore, doxycycline is being investigated as a potential adjuvant treatment—a treatment used alongside other cancer therapies. Doxycycline is thus a repurposed drug for cancer.
Important
Doxycycline must not be taken simultaneously with dairy products, calcium supplements, or magnesium (e.g., in multivitamins), as these bind the medicine and prevent absorption. Optimally, it should be taken with a large glass of water (at least 200 ml) at least 1 hour before food or bedtime to protect the esophagus.
Note:
- If it causes stomach pain or nausea on an empty stomach (which is frequent), it may be taken with food.
Warning:
- Regardless of whether you take it with or without food, the meal must not contain dairy products, calcium, or magnesium, as this blocks the effect. Maintain at least a 2-hour interval from dairy products and minerals. It can be taken with food to protect the stomach, as long as it is calcium-free.
Effect and Mechanism of Action
Although the precise mechanism behind doxycycline’s cancer-fighting properties is still being investigated, several studies have pointed to the following possible mechanisms:
Inhibition of tumor growth
Doxycycline can directly inhibit the growth of certain cancer cells by affecting their cell cycle and inducing cell death (apoptosis). Doxycycline can induce cancer cells to commit suicide.
Counteracting angiogenesis
Angiogenesis is the formation of new blood vessels, which cancer tumors need to grow. Doxycycline can inhibit this process, which can slow tumor growth. Cancer tumors need new blood vessels to grow and to be able to spread.
Modulation of the immune system
Doxycycline can affect the immune system in various ways, for example, by increasing the activity of certain immune cells, which can help the body fight cancer cells more effectively. Doxycycline can thus improve the immune system’s ability to fight cancer cells.
Inhibition of metastases
Metastases are the spread of cancer cells to other parts of the body. Doxycycline can inhibit this process by affecting the cancer cells’ ability to invade and colonize new tissues.
Inhibition of protein synthesis
Doxycycline binds to the ribosomes of bacteria/cancer cells. Ribosomes are the cells’ protein factories. They read the genetic code in mRNA and use it to build proteins necessary for all living organisms. By binding to cancer cells, they can prevent them from producing the proteins they need to survive and reproduce. Thereby, doxycycline inhibits the protein synthesis of cancer cells. Cancer cells—just like bacteria—divide rapidly and therefore have a high need to produce new proteins. By blocking this process, doxycycline can also prevent cancer cells from growing and dividing.
The potential for doxycycline in cancer treatment is due to several factors:
Broad-spectrum effect:
- Doxycycline may be effective against various types of cancer cells.
Relatively low toxicity:
- Compared to many chemotherapeutic agents, doxycycline has a relatively low toxicity profile.
Adjuvant Treatment
Doxycycline is being investigated as a potential adjuvant treatment for a variety of cancers, including:
Hematological cancers:
Solid tumors:
- Such as breast cancer, lung cancer, and prostate cancer.
Furthermore, it is used by a number of doctors as an adjuvant treatment for cancer in connection with 3 other drugs in a context called The COC Protocol.
It must be emphasized that doxycycline is not a standard treatment for cancer. Research is still in an early phase, and more clinical studies are needed to determine if doxycycline can be a safe and effective treatment for cancer patients. However, it should also be emphasized that quite a few people are prescribed it as an adjuvant treatment against cancer in connection with the aforementioned COC Protocol.
Read about The COC Protocol.
Side Effects
Doxycycline is an effective antibiotic, but as with all medicine, it can also cause side effects. These can vary from person to person and depend on several factors, including dose, treatment duration, and the individual’s general health.
Common Side Effects
Gastrointestinal problems
This is one of the most common side effects and can include:
- Diarrhea
- Nausea
- Vomiting
- Stomach pain
- Loss of appetite
- Constipation
Skin reactions
- Rash
- Increased sensitivity to sunlight (photosensitization):
- A common side effect of using doxycycline is increased sensitivity to sunlight. This means that the skin may react more strongly to the sun’s rays, resulting in sunburn (even with short-term exposure), rash, and/or itching.
- Increased risk of sunburn: You can get sunburned much faster and more severely than normal.
- Skin rash: Some people may develop a rash after exposure to sunlight while on doxycycline.
- Itching: Your skin may become itchy after being in the sun.
- Skin discoloration: In rare cases, doxycycline can lead to changes in skin color after exposure to sunlight.
- Photo-onycholysis: This is a rare reaction where your fingernails may begin to detach from the nail bed due to sunlight exposure.
- With fixed, continuous use of doxycycline: If you—as with The COC Protocol—take doxycycline daily without breaks, your skin will be persistently more sensitive to sunlight throughout the treatment period. It is therefore crucial that you take all necessary precautions to protect yourself from the sun every day. This includes avoiding direct sunlight during the most intense hours (between 10 AM and 3 PM), using high-factor sunscreen (SPF 30 or higher, and consider SPF 50 for extra protection), wearing protective clothing (long sleeves, long pants, hat), and sunglasses.
- With alternating use (e.g., 1 month doxycycline, 1 month Vermox): Even if you take breaks from doxycycline, there may still be increased sensitivity to sunlight for some days (and up to a week) after you have stopped taking it. Although the highest concentration of doxycycline drops quickly, it can take some time before the medicine is completely out of the body. Therefore, it is recommended that you continue to be extra careful with the sun for at least a week after the doxycycline period ends, before you can be less cautious during the period where you pause (and take Vermox instead). Vermox does not cause increased sensitivity to sunlight. When you resume doxycycline treatment, your sensitivity to the sun will increase again.
- A common side effect of using doxycycline is increased sensitivity to sunlight. This means that the skin may react more strongly to the sun’s rays, resulting in sunburn (even with short-term exposure), rash, and/or itching.
It is important to be consistent with sun protection throughout the doxycycline treatment course, whether it is fixed or in cycles, and for a period after use ends. Be aware that individual reactions can vary, and you should talk to your doctor or practitioner if you experience severe reactions to the sun.
Applies to the entire group
Unfortunately, photosensitivity is a known side effect for the entire tetracycline class of antibiotics. This means that other preparations in this group, such as tetracycline and minocycline, can also cause increased sensitivity to sunlight, although the degree of sensitivity may vary slightly between the different tetracyclines. Some sources suggest that minocycline may cause less photosensitivity than doxycycline, but this is still not clarified and must therefore also be considered a potential side effect to be fully aware of.
Fungal infections
Doxycycline can suppress the natural bacterial flora in the body and thus allow for fungal infections, such as:
- Oral thrush
- Vaginal yeast infection
Other side effects
- Headache
- Dizziness
- Fatigue
Less common but serious side effects
Liver impact
This can be serious and requires immediate medical attention. Symptoms may include:
- Jaundice (yellow color in skin and eyes)
- Dark urine
- Pale stools
- Itching
Kidney problems
- Doxycycline can in rare cases affect kidney function.
Allergic reactions
- These can be mild (e.g., rash) or severe (anaphylactic shock).
Side effects in children
Discoloration of teeth:
- Doxycycline can cause permanent discoloration of teeth in children if taken during tooth formation.
Inhibited bone growth:
- Long-term use of doxycycline in children can affect bone growth.
Note
Doxycycline must not be taken with dairy products, as it can reduce the effect. There should be as much time as possible between the intake of Doxycycline and dairy products.
Doxycycline should also not be taken with alcohol, as this can increase the risk of side effects.
Conclusion
Based on the aforementioned anti-cancer effects, doxycycline has been investigated as a potential treatment for a variety of cancers, including breast cancer, lung cancer, colorectal cancer, and melanoma. Doxycycline is still an off-label medication. However, it must be said to be extremely interesting. As with all other treatment in a cancer context, it is necessary to weigh side effects against the risk of the disease’s progression if left untreated. If you are considering using doxycycline as part of your cancer treatment, you must talk to your doctor about the benefits and risks. Furthermore, be aware that certain drugs can interact, potentially causing unintended effects when combined. If you are in doubt, it can be checked here: Drugs.com
See also Repurposed Drugs
See also No medicine – Plan B
Links
Interactions (search for preparations) (Interaktionsdatabasen, Danish Medicines Agency) (Danish Language)
Antimicrobial Agents for Cancer Therapy (PubMed)
Doxycycline as a Cancer Treatment (Omega Cancer Center)
Brief look at antitumor effects of doxycycline in the treatment of colorectal cancer (Science Direct)
Doxycycline directly targets PAR1 to suppress tumor progression (PubMed)
Matrix metalloproteinase 9 implication during colorectal carcinogenesis. Effect of doxycycline (PubMed, 2025)
- Content: Overexpression of MMP9 occurs early during colorectal carcinogenesis, and doxycycline can control the pathological conversion of the colonic mucosa into ACF clusters by decreasing MMP9 activity.
- Content: A pilot study in breast cancer patients shows that the antibiotic doxycycline appears to be able to eliminate aggressive cancer stem cells (CSCs). This was measured by a decrease in known stem cell markers (CD44 and ALDH1). Although results are promising, larger studies are needed to confirm the finding.
- Content: A combination of two antibiotics (Doxycycline and Azithromycin) and Vitamin C acts as a “metabolic trap” that, in laboratory experiments, stopped over 90% of breast cancer stem cell growth by paralyzing their energy production.
- Content: Doxycycline can help in metastatic prostate cancer by lowering PSA and improving quality of life. Further larger studies are needed to confirm this.
Impact of medications on the efficacy of immune checkpoint inhibitors in patients with recurrent or metastatic head and neck cancer (PubMed, 2025)
- Content: Antibiotic treatment was associated with poorer survival in patients with RM-HNC receiving immunotherapy. This highlights the need for careful assessment of antibiotic use and the need for more research to improve treatment.
Doxycycline sensitizes renal cell carcinoma to chemotherapy by preferentially inhibiting mitochondrial translation (PubMed, 2021)
- Content: This study shows that doxycycline can make kidney cancer cells more sensitive to chemotherapy. The mechanism is that doxycycline specifically inhibits the cancer cells’ mitochondria (the cell’s power plants), which disrupts their energy production and makes them more vulnerable to the cell damage caused by the chemotherapy.
Targeting Mitochondria for Treatment of Chemoresistant Ovarian Cancer (MDPI, 2019)
- Content: An article specifically describing how one can attack cancer cells’ power plants (mitochondria) to fight resistant ovarian cancer – exactly the mechanism Doxycycline uses.
Page created: July 1, 2024, Last revised September 16, 2025
❤
What you read on Jeg har Kræft is not a recommendation. Seek competent guidance.